Study of Brain Monitoring with Pulsatile Near Infrared Spectroscopy in Newborns Right After Birth

What this Trial Is About

The transition from fetus to newborn is a complex process that requires careful monitoring to detect any problems early. This trial focuses on neonatal disease by evaluating cerebral monitoring using a new pulsatile near-infrared spectroscopy NIRS method immediately after birth. Traditional methods like the Apgar score and standard monitoring of oxygen saturation and heart rate have limitations, especially in assessing brain oxygenation and blood flow during this critical time. The study is observational and aims to explore this innovative approach in newborns, including both term and preterm infants. The new pulsatile NIRS technique, used with the NIRO 200 NX device, measures cerebral pulse rate and arterial oxygen saturation in small brain vessels continuously and non-invasively. Unlike conventional NIRS, it captures data at a higher rate to provide better insight into brain oxygenation and blood flow. The study involves no intervention and observes neonates routinely at the resuscitation desk, with groups including term and preterm babies. This method could help identify brain oxygen supply issues early and guide potential interventions in the future. Participants, both term and preterm neonates, will be monitored right after birth during routine care at the resuscitation station. Researchers will measure the percentage of cerebral oxygenation in pulsatile cerebral vessels over 15 minutes. No active treatments are given as part of the study. The goal is to collect data that may improve understanding of brain oxygen delivery during the vulnerable newborn transition. The study requires parental consent and includes follow-up to ensure safety and accurate data collection during this early period of life.

Cerebral Monitoring Using Pulsatile Near Infrared Spectroscopy in Neonates